Lotte Chemical Corporation (011170) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
10 Sep, 2026Executive summary
Full-year 2025 sales declined 7.1% year-over-year to KRW 18.483 trillion, with an operating loss of KRW 943.6 billion, mainly due to delayed recovery in the petrochemical sector and increased losses at Lotte Energy Materials.
Fourth quarter sales were KRW 4.7099 trillion, with an operating loss of KRW 433.9 billion, reflecting seasonal demand weakness and initial ramp-up costs at LCI.
Significant asset impairment losses in Q4 led to a net loss of KRW 1.609 trillion.
Net loss for FY2025 is expected to widen to 2.49 trillion KRW from 1.83 trillion KRW in FY2024.
Financial highlights
EBITDA loss for Q4 was KRW 69.5 billion.
FY2025 EBITDA is projected at 376.1 billion KRW, down from 311 billion KRW in FY2024.
Cash and cash equivalents at Q4 2025 stood at 3.43 trillion KRW, up 17.4% sequentially.
Loss before tax in Q4 reached KRW 1.7363 trillion, driven by asset impairments.
As of Q4-end, assets stood at KRW 31 trillion, liabilities at KRW 13 trillion, and shareholder equity at KRW 18 trillion; debt-to-equity ratio was 76.4%.
Outlook and guidance
Profitability is expected to improve quarter-on-quarter in Basic Chemicals and Advanced Materials as off-peak season ends and operational stability increases.
Advanced materials and precision chemicals anticipate modest recovery as inventory adjustments end and demand stabilizes.
Lotte Fine Chemical expects flat profitability in Q1, while Lotte Energy Materials anticipates further improvement from portfolio diversification.
Ongoing business transformation focuses on reducing commodity petrochemical exposure and expanding high-value and eco-friendly products.
Latest events from Lotte Chemical Corporation
- Q2 2024 sales rose, losses narrowed, and strategic investments in hydrogen and batteries continued.011170
Q2 2024 - Impairment losses led to deep 2024 losses, but gradual recovery and asset-light progress are expected.011170
Q4 2024 - Q3 2024 revenue was flat, losses widened, and asset sales and investments continue amid weak demand.011170
Q3 2024 - Q1 2025 losses narrowed as advanced and fine chemicals improved, but margin pressures persist.011170
Q1 2025 - Losses widened, but recovery is expected as portfolio shifts and new projects progress.011170
Q2 2025 - Q3 2025 returned to profit, but 9M results show losses; focus shifts to battery and hydrogen.011170
Q3 2025 - Q2 2026 delivered higher profits and restructuring progress, despite ongoing market risks.011170
Q2 2026 - Q1 2026 returned to profit with KRW 4.99T revenue and KRW 49.6B net income amid ongoing risks.011170
Q1 2026